Lanvis (treatment of leukaemias)
- Date:
- c.1974 -c.1981
- Reference:
- WF/M/PL/174
- Part of:
- Wellcome Foundation Ltd
- Archives and manuscripts
About this work
Description
Lanvis (treatment of leukaemias). Cytostatic agent. Main indication is acute myeloblastic leukaemia, but it has also been used in acute lymphoblasic and chronic granulocytic leukaemia. Used in cancer chemotherapy, in tablet form.
The folder includes a photocopy extract from Wellcome Medical Division, page 1102 re. Lanvis Tablets; colour transparancy of Lanvis product;"Dear Sir" and "Dear Doctor" letters, a bibliography of published papers; booklets on Lanvis for clinicians and therapy for leukaemia.
Publication/Creation
c.1974 -c.1981
Physical description
1 Item
Copyright note
Copyright assigned to the Wellcome Trust
Where to find it
Location Status Access Closed stores